Abstract
Di(2-ethylhexyl)phthalate (DEHP) and mono(2-ethylhexyl)phthalate (MEHP) were administered PO or IP to pregnant ICR mice at varying doses on days 7, 8, and 9 of gestation. In groups given DEHP orally, resorptions and malformed fetuses increased significantly at 1,000 mg/kg. Fetal weights were also significantly suppressed. Anterior neural tube defects (anencephaly and exencephaly) were the malformations most commonly produced. No teratogenic effects were revealed by IP doses of DEHP and PO or IP doses of MEHP, although high doses were abortifacient and lethal to pregnant females. Thus DEHP is highly embryotoxic and teratogenic in mice when given PO but not IP. The difference in metabolism, disposition, or excretion by the route of administration may be responsible for the difference in DEHP teratogenicity. Although MEHP is a principal metabolite of DEHP and is several times more toxic than DEHP to adult mice, it seems that MEHP and its metabolites are not teratogenic in ICR mice.
Similar content being viewed by others
References
Albro PW, Corbett JT, Schroeder JL, Jordan S, Matthews HB (1982) Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP. Environ Health Perspect 45: 19–25
Daniel JW, Bratt H (1974) The absorption, metabolism and tissue distribution of di(2-ethylhexyl) phthalate in rats. Toxicology 2: 51–65
Gibson TP, Briggs WA, Boone BJ (1976) Delivery of di-2-ethylhexyl phthalate to patients during hemodialysis. J Lab Clin Med 87: 519–524
Jaeger RJ, Rubin RJ (1972) Migration of a phthalate ester plasticizer from polyvinyl chloride blood bags into stored human blood and its localization in human tissues. N Engl J Med 287: 1114–1118
Jensh RP, Brent RL, Barr M Jr (1970) The litter effect as a variable in teratologic studies of the albino rat. Am J Anat 128: 185–191
Kluwe WM (1982) Overview of phthalate ester pharmacokinetics in mammalian species. Environ Health Perspect 45: 3–10
Nakamura Y, Yagi Y, Tomita I, Tsuchikawa K (1979) Teratogenicity of di-(2-ethylhexyl) phthalate in mice. Toxicol Lett 4: 113–117
Nikonorow M, Mazur H, Piekacz H (1973) Effect of orally administered plasticizers and polyvinyl chloride stabilizers in the rat. Toxicol Appl Pharmacol 26: 253–259
Ruddick JA, Villeneuve DC, Chu I, Nestmann E, Miles D (1981) An assessment of the teratogenicity in the rat and mutagenicity in salmonella of mono-2-ethylhexyl phthalate. Bull Environ Contam Toxicol 27: 181–186
Seed JL (1982) Mutagenic activity of phthalate esters in bacterial liquid suspension assays. Environ Health Perspect 45: 111–114
Shiota K, Nishimura H (1982) Teratogenicity of di(2-ethylhexyl) phthalate (DEHP) and di-n-butyl phthalate (DBF) in mice. Environ Health Perspect 45: 65–70
Singh AR, Lawrence WH, Autian J (1972) Teratogenicity of phthalate esters in rats. J Pharm Sci 61: 51–55
Thomas JA, Darby TD, Wallin RF, Garvin PJ, Martis L (1978) A review of the biological effects of di-(2-ethylhexyl) phthalate. Toxicol Appl Pharmacol 45: 1–27
Thomas JA, Schein LG, Gupta PK, McCafferty RE, Felice PR, Donovan MP (1979) Failure of monoethylhexyl phthalate to cause teratogenic effects in offspring of rabbits. Toxicol Appl Pharmacol 51: 523–528
Tomita I, Nakamura Y, Yagi Y (1977) Phthalic acid esters in various foodstuffs and biological materials. Toxicol Environ Safety 1: 275–287
Wilcoxon F, Wilcox RA (1964) Some rapid statistical procedures. Lederle Laboratories, Pearl River, NY
Zeiger E, Haworth S, Speck W, Mortelmans K (1982) Phthalate ester testing in the National Toxicology Program's environmental mutagenesis test development program. Environ Health Perspect 45: 99–101
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shiota, K., Mima, S. Assessment of the teratogenicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate in mice. Arch Toxicol 56, 263–266 (1985). https://doi.org/10.1007/BF00295165
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00295165